Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
- PMID: 22077417
- DOI: 10.1111/j.1365-2141.2011.08928.x
Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
Abstract
Lymphomas can arise within the central nervous system (CNS) as primary CNS lymphoma (PCNSL) typically involving the brain and less often the leptomeninges, eyes, and spinal cord. In contrast to PCNSL, secondary CNS lymphoma (SCNSL) is considered to originate as quasi metastasis from systemic lymphoma spreading to the CNS. Both types of CNS lymphomas are predominantly tumours of the diffuse large B-cell type and represent aggressive diseases necessitating a rapid diagnosis. Following neuroimaging based on magnetic resonance imaging, stereotaxy and histopathological diagnosis of CNS lymphoma currently remain obligatory to plan treatment. However, progress in cytopathological, immunophenotypic, and molecular genetic analyses of the cerebrospinal fluid (CSF) has been achieved recently and potentially will facilitate lymphoma diagnosis in the future. This review describes the diagnostic procedures in patients with suspected CNS lymphomas, primarily PCNSL. In addition to a summary of the standard diagnostic work-up, an overview and discussion of current data on different techniques for evaluation of the CSF in CNS lymphoma are given.
© 2011 Blackwell Publishing Ltd.
Similar articles
-
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.Eur J Haematol. 2010 Dec;85(6):520-8. doi: 10.1111/j.1600-0609.2010.01516.x. Epub 2010 Oct 28. Eur J Haematol. 2010. PMID: 20727005 Clinical Trial.
-
Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.Eur J Haematol. 2010 Sep;85(3):236-42. doi: 10.1111/j.1600-0609.2010.01475.x. Epub 2010 May 26. Eur J Haematol. 2010. PMID: 20528903
-
Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.CNS Oncol. 2014 Jan;3(1):77-85. doi: 10.2217/cns.13.63. CNS Oncol. 2014. PMID: 25054902 Free PMC article. Review.
-
Treatment options for central nervous system lymphomas in immunocompetent patients.Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100. Expert Rev Neurother. 2009. PMID: 19831839
-
Primary lymphoma of the central nervous system.Ophthalmol Clin North Am. 2005 Mar;18(1):199-207, x. doi: 10.1016/j.ohc.2004.08.009. Ophthalmol Clin North Am. 2005. PMID: 15763205 Review.
Cited by
-
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.Neuro Oncol. 2017 Nov 29;19(12):1618-1627. doi: 10.1093/neuonc/nox097. Neuro Oncol. 2017. PMID: 28521029 Free PMC article.
-
Primary hypothalamic lymphoma with clinical findings mimicking pituitary apoplexy: a case report.J Med Case Rep. 2021 May 25;15(1):293. doi: 10.1186/s13256-021-02866-7. J Med Case Rep. 2021. PMID: 34030739 Free PMC article.
-
A Demyelinating Disease; What Lies Beneath?Indian J Pediatr. 2016 Apr;83(4):365-7. doi: 10.1007/s12098-015-1849-5. Epub 2015 Jul 25. Indian J Pediatr. 2016. PMID: 26204979 No abstract available.
-
Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.BMC Neurol. 2019 Nov 4;19(1):268. doi: 10.1186/s12883-019-1511-3. BMC Neurol. 2019. PMID: 31684888 Free PMC article.
-
MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.Front Oncol. 2021 Sep 17;11:743542. doi: 10.3389/fonc.2021.743542. eCollection 2021. Front Oncol. 2021. PMID: 34604087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources